chr9-101594414-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_147180.4(PPP3R2):c.508G>A(p.Val170Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00008 in 1,599,258 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_147180.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP3R2 | NM_147180.4 | c.508G>A | p.Val170Ile | missense_variant | 1/1 | ENST00000374806.2 | NP_671709.2 | |
GRIN3A | NM_133445.3 | c.2767-15054G>A | intron_variant | ENST00000361820.6 | NP_597702.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP3R2 | ENST00000374806.2 | c.508G>A | p.Val170Ile | missense_variant | 1/1 | 6 | NM_147180.4 | ENSP00000363939.2 | ||
PPP3R2 | ENST00000636434.1 | c.208G>A | p.Val70Ile | missense_variant | 2/2 | 1 | ENSP00000490051.1 | |||
GRIN3A | ENST00000361820.6 | c.2767-15054G>A | intron_variant | 1 | NM_133445.3 | ENSP00000355155.3 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000942 AC: 23AN: 244080Hom.: 1 AF XY: 0.0000684 AC XY: 9AN XY: 131630
GnomAD4 exome AF: 0.0000788 AC: 114AN: 1446940Hom.: 1 Cov.: 31 AF XY: 0.0000753 AC XY: 54AN XY: 717530
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.517G>A (p.V173I) alteration is located in exon 1 (coding exon 1) of the PPP3R2 gene. This alteration results from a G to A substitution at nucleotide position 517, causing the valine (V) at amino acid position 173 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at